ArticleArchives of medical science : AMS2026

Early treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis.

Adam Stepień et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.